Reni Benjamin

Stock Analyst at JMP Securities

(1.47)
# 3,348
Out of 4,884 analysts
194
Total ratings
39.75%
Success rate
-12.78%
Average return

Stocks Rated by Reni Benjamin

Blueprint Medicines
Jun 3, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $128.35
Upside: -
Inhibrx Biosciences
May 15, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $16.33
Upside: -
Bicycle Therapeutics
May 2, 2025
Maintains: Market Outperform
Price Target: $26$22
Current: $7.43
Upside: +196.10%
Cue Biopharma
Apr 2, 2025
Reiterates: Market Outperform
Price Target: $2
Current: $0.70
Upside: +187.69%
BioAtla
Mar 31, 2025
Maintains: Market Outperform
Price Target: $5$1
Current: $0.38
Upside: +165.89%
Allogene Therapeutics
Mar 14, 2025
Upgrades: Market Outperform
Price Target: $5
Current: $1.19
Upside: +320.17%
Incyte
Mar 11, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $68.45
Upside: -
Adicet Bio
Mar 7, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.61
Upside: -
Werewolf Therapeutics
Jan 14, 2025
Maintains: Market Outperform
Price Target: $12$4
Current: $1.07
Upside: +273.83%
Compugen
Aug 8, 2022
Maintains: Market Outperform
Price Target: $8$4
Current: $1.76
Upside: +127.27%
Upgrades: Market Perform
Price Target: n/a
Current: $2.28
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $1.07
Upside: -
Reinstates: Market Perform
Price Target: n/a
Current: $7.36
Upside: -
Maintains: Outperform
Price Target: $20$16
Current: $0.25
Upside: +6,300.00%
Maintains: Outperform
Price Target: $11$10
Current: $18.28
Upside: -45.30%
Reiterates: Market Outperform
Price Target: $5
Current: $3.19
Upside: +56.74%
Reiterates: Market Outperform
Price Target: $28
Current: $5.86
Upside: +377.82%
Reiterates: Market Perform
Price Target: n/a
Current: $27.50
Upside: -
Reiterates: Market Outperform
Price Target: $40
Current: $24.55
Upside: +62.93%
Reiterates: Market Perform
Price Target: n/a
Current: $1.32
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $1.75
Upside: -
Reiterates: Market Outperform
Price Target: $4
Current: $0.79
Upside: +403.84%
Downgrades: Market Perform
Price Target: n/a
Current: $0.76
Upside: -
Maintains: Market Outperform
Price Target: $7$8
Current: $8.23
Upside: -2.79%
Reiterates: Market Outperform
Price Target: $60
Current: $56.01
Upside: +7.12%
Reiterates: Market Perform
Price Target: n/a
Current: $8.62
Upside: -
Reiterates: Market Outperform
Price Target: $315
Current: $241.76
Upside: +30.29%
Reiterates: Market Perform
Price Target: n/a
Current: $93.63
Upside: -
Reiterates: Market Outperform
Price Target: $265
Current: $237.55
Upside: +11.56%
Downgrades: Outperform
Price Target: $28$17
Current: $3.20
Upside: +431.25%
Downgrades: Market Perform
Price Target: n/a
Current: $0.29
Upside: -
Reinstates: Outperform
Price Target: n/a
Current: $8.74
Upside: -
Upgrades: Market Perform
Price Target: n/a
Current: $1.46
Upside: -
Downgrades: Outperform
Price Target: $22$12
Current: $36.72
Upside: -67.32%
Downgrades: Market Perform
Price Target: n/a
Current: $13.58
Upside: -